OVERVIEW

The New Paradigm of Treatment For The Headache Patient is organized by Diamond Headache Clinic Research & Educational Foundation (DHCREF).

Virtual Event Launch: August 28, 2020
This virtual program will be available until August 28, 2021

Accreditation
ACCME:
Forefront Collaborative designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP:
The AAFP has reviewed The New Paradigm of Treatment for the Headache Patient and deemed it acceptable for up to 4.25 Enduring Materials, Self-Study AAFP Prescribed credit. Term of Approval is from 08/28/2020 to 08/28/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Overview:
In the United States, 1.4 percent of all visits to office-based physicians are due to headache, which represents approximately 12 million physician visits in one year. According to recent studies, 8.7 million females and 2.6 million males in the US alone experience migraine. Existing and ongoing research activity in the field of headache has produced clinical data of which primary care providers should be cognizant in order to provide optimal care to headache sufferers. These data have significant implications for diagnosis and treatment and may challenge current assumptions about the role of healthcare professionals in the management of primary headache disorders. Practitioners should be knowledgeable about new findings concerning pharmacological agents used for the treatment of headache, including new formulations of existing medications and those recently available for headache management.

After participating in this educational activity, participants should be better able to
• Incorporate the differential diagnoses of headache disorders in order to choose the best treatment strategies
• Analyze safety and efficacy data for new and emerging therapies in the treatment of migraine
• Develop and implement treatment plans in line with standards of practice for acute management of migraine
• Develop and implement preventive treatment as migraine is progressing and transforming
• Use effective therapeutic tools that address the gender-specific challenges of treating women with migraine

Topics:
• Migraine Update: How New Treatment Options Are Changing Patient Lives
• New Preventive Therapies: Science and Mechanisms (MABS/Gepants)
• Preventative Treatment: How Do We Integrate New Treatments and What Are Outcomes
• New Acute Therapies: Science and Mechanisms
• Acute Treatment: How Do We Integrate New Treatments and What Are Outcomes
• Devices, Injections and Interventional Therapies Including OnabotulinumtoxinA
• Medication Overuse Headache: How Has The World Changed With The New Therapies
• An Integrated Treatment Approach Using Outpatient and Inpatient Services
• Women and Migraine: Gender Based Approach and Treatment Options
• Accessing Headache Care Through A Virtual Medicine Platform
• Cluster Headaches, TAC and Other Less Common Headache Types
• Round Table Discussion: How Have The New Therapies Changed Your General Approach To Treating Patients In Your Practice?